Our technology () is built on two basic capabilities: the use of genetic engineering to attach high-value proteins to (the structures used by seeds to store oil); and extraction of oilbodies from seeds in a cost-effective manner.
We have chosen safflower as our commercial plant variety. Through genetic manipulation (transgenic), or physical manipulation (non-transgenic) of safflower oilbodies, SemBioSys is able to capitalize on the scalability and economic advantages of plants to produce a wide variety of products such as human pharmaceuticals, personal care ingredients, nutritional oils and agricultural biotechnology products.
For the production of high-value proteins, we believe that our plant technology is unique among transgenic systems as it addresses both production and purification challenges. Because of this, SemBioSys' technology creates a cost-effective solution for the production of pharmaceuticals that are required in large quantities due to the number of people affected by the disease and/or high dosage requirements.